NVO

Novo Nordisk A/S NYSE

Healthcare ·Drug Manufacturers - General ·DK · novonordisk.com

$43.88

Mkt Cap $195.2B

52w Low $35.12 18.9% of range 52w High $81.44

50d MA $38.87 200d MA $50.32

P/E (TTM) 1.9x

EV/EBITDA 9.8x

P/B 1.0x

Debt/Equity 0.7x

ROE —

P/FCF 49.6x

RSI (14) —

ATR (14) —

Beta 0.27

50d MA $38.87

200d MA $50.32

Avg Volume 22.0M

About

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, o…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 3, 2026	AMC	0.90	1.00	+11.1%	50.30	-4.7%	-6.2%	-13.8%	-5.3%	-1.8%	-2.3%	-22.3%	—
Nov 5, 2025	AMC	0.77	1.02	+32.5%	48.46	-1.5%	-4.0%	-5.7%	-5.2%	+1.4%	+3.7%	-1.2%	—
Aug 6, 2025	AMC	0.93	0.97	+4.3%	45.38	+6.8%	+7.4%	+12.6%	+9.9%	+9.7%	+12.2%	+21.7%	—
May 7, 2025	AMC	0.92	0.92	+0.0%	67.55	-2.4%	-4.0%	-2.6%	+0.3%	-3.2%	-4.6%	+10.5%	—
Feb 5, 2025	AMC	0.88	0.91	+3.4%	85.73	+1.2%	+1.7%	+0.8%	-2.1%	-2.3%	-4.6%	+1.7%	—
Nov 6, 2024	AMC	0.87	0.88	+1.4%	105.36	+0.7%	+2.2%	+1.7%	+3.5%	+1.6%	+1.5%	+5.1%	—
Aug 7, 2024	AMC	0.70	0.66	-5.9%	119.23	+5.6%	+7.5%	+11.9%	+8.9%	+12.0%	+12.7%	+10.0%	—
May 2, 2024	AMC	0.74	0.82	+10.5%	124.02	-0.9%	-0.8%	+0.5%	+2.6%	+2.2%	+3.7%	+9.4%	—
Jan 31, 2024	AMC	0.65	0.71	+9.5%	114.74	-0.6%	+0.9%	-0.9%	+3.1%	+2.5%	+3.4%	+8.3%	—
Nov 2, 2023	AMC	0.71	0.71	+0.0%	100.93	-2.2%	-2.7%	+0.1%	+0.8%	+0.8%	-0.9%	-0.0%	—
Aug 10, 2023	AMC	0.67	0.63	-6.0%	91.05	+0.2%	-0.3%	-1.5%	+1.7%	+1.4%	+1.4%	+9.6%	—
May 4, 2023	AMC	0.63	0.63	+0.0%	80.22	+1.1%	+1.7%	+5.0%	+5.0%	+5.6%	+5.3%	-1.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 2	Goldman Sachs	Downgrade	Buy → Neutral	—	$37.45	$36.83	-1.7%	+0.8%	-2.1%	+2.8%	+4.3%	+3.0%
Feb 24	JP Morgan	Downgrade	Overweight → Neutral	—	$39.63	$38.50	-2.9%	-2.6%	-3.7%	-5.1%	-5.5%	-4.7%
Dec 8	Argus	Downgrade	Buy → Hold	—	$47.86	$47.16	-1.5%	-2.3%	-3.1%	+2.5%	+5.1%	+4.8%
Nov 28	Goldman Sachs	Maintains	Buy → Buy	—	$48.71	$49.13	+0.9%	+1.3%	-0.6%	-2.6%	-2.3%	-1.5%
Nov 25	BMO Capital	Maintains	Market Perform → Market Perform	—	$44.97	$45.98	+2.2%	+4.6%	+8.3%	+9.7%	+7.7%	+5.5%
Nov 24	HSBC	Downgrade	Buy → Hold	—	$47.63	$43.43	-8.8%	-5.6%	-1.2%	+2.3%	+3.6%	+1.7%
Oct 14	BMO Capital	Maintains	Market Perform → Market Perform	—	$57.50	$56.28	-2.1%	-1.5%	-1.4%	-2.5%	-5.4%	-3.1%
Oct 2	HSBC	Upgrade	Hold → Buy	—	$59.17	$58.88	-0.5%	-0.7%	+0.8%	+0.8%	-0.3%	+0.7%
Sep 29	Morgan Stanley	Downgrade	Equal Weight → Underweight	—	$55.61	$54.14	-2.6%	-0.2%	-0.2%	+6.4%	+5.6%	+7.2%
Sep 17	Berenberg	Upgrade	Hold → Buy	—	$57.20	$57.78	+1.0%	+1.7%	+8.1%	+7.3%	+6.1%	+4.1%
Aug 19	TD Cowen	Maintains	Buy → Buy	—	$53.75	$54.57	+1.5%	+1.9%	+1.0%	+3.2%	+6.0%	+4.8%
Aug 5	UBS	Downgrade	Buy → Neutral	—	$48.81	$47.88	-1.9%	-3.3%	-7.0%	-0.1%	+4.7%	+2.2%
Jul 31	HSBC	Downgrade	Buy → Hold	—	$50.03	$48.96	-2.1%	-5.9%	-3.7%	-2.4%	-5.6%	-9.3%
Jul 30	Barclays	Downgrade	Overweight → Equal Weight	—	$53.94	$51.26	-5.0%	-7.2%	-12.7%	-10.7%	-9.5%	-12.5%
Jun 18	TD Cowen	Maintains	Buy → Buy	—	$74.34	$74.56	+0.3%	-0.4%	-0.8%	-6.2%	-4.9%	-9.4%
Apr 17	BMO Capital	Downgrade	Outperform → Market Perform	—	$62.88	$57.91	-7.9%	-7.6%	-7.2%	-4.7%	-2.5%	-0.4%
Jan 8	UBS	Upgrade	Sell → Buy	—	$83.34	$85.51	+2.6%	+2.8%	+3.5%	+1.5%	-2.6%	-0.5%
Dec 23	BMO Capital	Maintains	Outperform → Outperform	—	$85.00	$88.87	+4.6%	+4.4%	+2.8%	+3.1%	+2.8%	+0.9%
Nov 6	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$110.13	$108.27	-1.7%	-4.3%	-2.3%	-2.7%	-0.9%	-2.8%
Oct 22	Citigroup	Maintains	Buy → Buy	—	$117.33	$115.00	-2.0%	-0.7%	-1.4%	-2.9%	-3.4%	-4.2%
Oct 17	BMO Capital	Maintains	Outperform → Outperform	—	$118.03	$118.59	+0.5%	+0.2%	+0.1%	-0.6%	-1.3%	-1.9%
Oct 16	Barclays	Maintains	Overweight → Overweight	—	$117.81	$116.95	-0.7%	+0.2%	+0.3%	+0.2%	-0.4%	-1.1%
Oct 14	BMO Capital	Maintains	Market Perform → Market Perform	—	$120.04	$119.60	-0.4%	-0.2%	-1.9%	-1.7%	-1.5%	-1.6%
Oct 10	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$117.00	$117.98	+0.8%	+0.5%	+2.6%	+2.4%	+0.7%	+0.9%
Sep 20	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$134.88	$129.10	-4.3%	-5.5%	-8.3%	-7.0%	-5.9%	-7.8%
Sep 16	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$137.00	$138.06	+0.8%	-0.1%	-3.6%	-3.6%	-1.5%	-6.9%
Sep 9	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$131.14	$132.03	+0.7%	+0.6%	-1.0%	+3.1%	+4.2%	+4.5%
Aug 19	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$134.89	$135.07	+0.1%	+0.3%	+0.7%	+0.1%	+1.5%	+1.5%
Aug 8	BMO Capital	Maintains	Outperform → Outperform	—	$119.23	$125.89	+5.6%	+7.5%	+11.9%	+8.9%	+12.0%	+12.7%
Aug 5	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$127.49	$123.89	-2.8%	-1.2%	+2.1%	-6.5%	+0.5%	+4.7%
Jul 1	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$142.74	$143.59	+0.6%	+1.9%	+0.2%	-2.7%	-0.3%	+0.2%
Jun 25	BMO Capital	Maintains	Outperform → Outperform	—	$142.28	$145.51	+2.3%	+3.3%	+1.0%	+1.6%	+0.3%	+2.2%
Jun 20	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$140.80	$141.51	+0.5%	+0.1%	+0.8%	+1.1%	+4.3%	+2.0%
Jun 17	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$142.50	$142.00	-0.4%	-1.5%	-1.2%	-1.1%	-0.4%	-0.2%
Jun 10	Argus	Maintains	Buy → Buy	—	$142.88	$142.12	-0.5%	+0.5%	-0.8%	+0.3%	-0.3%	-0.3%
Apr 18	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$124.53	$123.30	-1.0%	-1.4%	-1.5%	+0.6%	+3.3%	+1.3%
Apr 5	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$123.96	$124.67	+0.6%	+1.5%	+2.8%	+0.7%	+0.8%	+1.2%
Apr 1	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$128.40	$129.11	+0.6%	-0.7%	-1.5%	-1.1%	-3.5%	-2.0%
Mar 20	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$131.37	$131.15	-0.2%	-0.8%	-1.2%	-2.0%	-1.8%	-1.5%
Mar 8	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$135.92	$133.90	-1.5%	-2.1%	-3.4%	-0.6%	-1.8%	-1.0%
Feb 20	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$124.01	$124.62	+0.5%	-2.1%	-2.5%	+0.4%	-0.5%	-0.4%
Feb 15	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$123.29	$122.78	-0.4%	-1.2%	+0.6%	-1.5%	-1.9%	+1.0%
Feb 14	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$119.99	$120.51	+0.4%	+2.8%	+1.5%	+3.4%	+1.2%	+0.8%
Feb 1	Argus	Maintains	Buy → Buy	—	$114.74	$114.00	-0.6%	+0.9%	-0.9%	+3.1%	+2.5%	+3.4%
Feb 1	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$114.74	$114.00	-0.6%	+0.9%	-0.9%	+3.1%	+2.5%	+3.4%
Dec 4	TD Cowen	Maintains	Outperform → Outperform	—	$100.40	$100.57	+0.2%	+0.5%	-0.8%	-2.8%	-3.6%	-3.7%
Dec 1	Argus	Maintains	Buy → Buy	—	$101.84	$101.10	-0.7%	-1.4%	-0.9%	-2.2%	-4.2%	-4.9%
Mar 29	TD Cowen	Maintains	Outperform → Outperform	—	$77.66	$78.12	+0.6%	+0.8%	+1.8%	+2.5%	+2.8%	+2.1%
Mar 28	BTIG	Maintains	Buy → Buy	—	$77.35	$77.83	+0.6%	+0.4%	+1.2%	+2.2%	+2.9%	+3.2%
Dec 12	TD Cowen	Maintains	Outperform → Outperform	—	$64.46	$64.77	+0.5%	+0.7%	+3.0%	+4.5%	+3.7%	+3.3%

Data updated apr 26, 2026 4:18pm · Source: massive.com